会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Controlled-release formulations containing tryptophan or its metabolites
    • 含有色氨酸或其代谢物的控制释放制剂
    • US07670619B2
    • 2010-03-02
    • US11201070
    • 2005-08-09
    • Bojidar Mihaylov
    • Bojidar Mihaylov
    • A61K9/20A61K31/05
    • A61K9/209A61K31/405
    • New controlled-release formulations containing tryptophan and/or its metabolites are described, as well as the process to obtain them in tablet forms suitable for oral administration in the treatment of pathologies or conditions related to serotonin deficiency in the Nervous System. The formulations are comprised in double-layer tablets, one layer containing 5-hyrohytryptophan released rapidly (phase “fast), the other layer containing tryptophan or 5-hydroxytryptophan, progressively released (“retarded”). The finished product is characterized by optimal differential release profile under physiological conditions. In all cases the release kinetics obtained is accurately time- and concentration-controlled, therefore avoiding fortuitous release of the active ingredients, and in clinical setting is free of undesirable side effects.
    • 描述了含有色氨酸和/或其代谢物的新的控制释放制剂,以及以适于口服给药的片剂形式获得它们以治疗与神经系统中的5-羟色胺缺乏有关的病症或病症的方法。 制剂包含在双层片剂中,一层含有快速释放的5-羟色氨酸(相“快”),另一层含有色氨酸或5-羟色氨酸,逐渐释放(“延迟”)。 成品的特征在于生理条件下的最佳差速释放曲线。 在所有情况下,获得的释放动力学是精确时间和浓度控制的,因此避免了活性成分的偶然释放,并且在临床设置中没有不期望的副作用。